FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 202 filers reported holding FIBROGEN INC in Q1 2021. The put-call ratio across all filers is 4.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $168,876 | -68.0% | 195,707 | 0.0% | 0.11% | -62.8% |
| Q2 2023 | $528,409 | -90.3% | 195,707 | -32.9% | 0.30% | -90.2% |
| Q1 2023 | $5,443,253 | -43.9% | 291,707 | -51.8% | 3.09% | -46.0% |
| Q4 2022 | $9,703,522 | +23.1% | 605,713 | 0.0% | 5.73% | +24.4% |
| Q3 2022 | $7,880,000 | +23.2% | 605,713 | 0.0% | 4.60% | +28.4% |
| Q2 2022 | $6,396,000 | -12.1% | 605,713 | +0.1% | 3.59% | +26.2% |
| Q1 2022 | $7,280,000 | -14.8% | 605,173 | -0.1% | 2.84% | +23.7% |
| Q4 2021 | $8,541,000 | +38.0% | 605,713 | 0.0% | 2.30% | +73.2% |
| Q3 2021 | $6,190,000 | -61.6% | 605,713 | 0.0% | 1.33% | -52.7% |
| Q2 2021 | $16,130,000 | -23.3% | 605,713 | 0.0% | 2.81% | -33.5% |
| Q1 2021 | $21,024,000 | -6.4% | 605,713 | 0.0% | 4.22% | +130.7% |
| Q4 2020 | $22,465,000 | – | 605,713 | – | 1.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |